Related Experiment Video
Updated: Jan 29, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
A global overview of microsporidia infection in HIV/AIDS patients: an updated systematic review and meta-analysis
Ali Asghari1, Mohammad Reza Mohammadi2, Roumina Norouzi3
1Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Background:
This study aimed to update the global estimates of microsporidia prevalence, species/genotype distribution and clinical correlates among human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients.
Methods:
A systematic search of international databases was conducted for studies published between 1 January 2017 and 11 October 2025. Pooled prevalence and odds ratios (ORs) were calculated using a random effects model with 95% confidence intervals (CIs).
Results:
Thirty-nine studies from 18 countries (24 cross-sectional, 15 case-control) were included. The pooled prevalence of microsporidia among HIV/AIDS patients was 12% (95% CI 8.9 to 16), significantly higher than in controls (1.9%; odds ratio 5.7 [95% CI 3.33 to 9.74]). A higher pooled prevalence of microsporidia infection was observed in studies published after 2020 (15.9%), in those with sample sizes ≤100 participants (19.2%), in patients with CD4 counts ≤200 cells/μl (58.4%) and in males (64.9%). The highest country-specific prevalence rates were reported from Malaysia (60.9%), Mexico (48.3%), Malawi (37.0%) and South Africa (32.9%). Enterocytozoon bieneusi was the predominant species, accounting for 24 identified genotypes, followed by Encephalitozoon intestinalis, E. cuniculi and E. hellem.
Conclusions:
Microsporidia remain a significant opportunistic pathogen in HIV/AIDS patients. Strengthened molecular surveillance, standardized diagnostic protocols and integration of microsporidia screening into HIV/AIDS care are essential to improve outcomes and control transmission.
Insights
Microsporidia infections are common in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients, affecting 12% globally. Early detection and integrated care are crucial for managing this opportunistic pathogen.
Area of Science:
- Infectious Diseases
- Parasitology
- Immunology
Background:
- Microsporidia are opportunistic pathogens frequently affecting immunocompromised individuals.
- Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients are particularly susceptible to microsporidial infections.
- Updated global estimates on microsporidia prevalence and distribution in HIV/AIDS patients are needed.
Purpose of the Study:
- To provide updated global estimates of microsporidia prevalence in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients.
- To determine the species and genotype distribution of microsporidia in this population.
- To identify clinical correlates associated with microsporidial infections in HIV/AIDS patients.
Main Methods:
- A systematic literature search was performed across international databases for studies published between January 2017 and October 2025.
- Pooled prevalence and odds ratios (ORs) were calculated using random-effects meta-analysis with 95% confidence intervals (CIs).
- Studies were categorized by publication date, sample size, CD4 counts, and patient demographics.
Main Results:
- Thirty-nine studies from 18 countries were included, revealing a pooled microsporidia prevalence of 12% in HIV/AIDS patients, significantly higher than controls (1.9%).
- Higher prevalence was noted in studies post-2020 (15.9%), smaller sample sizes (19.2%), CD4 counts ≤200 cells/μl (58.4%), and in males (64.9%).
- Enterocytozoon bieneusi was the predominant species, with high country-specific prevalence in Malaysia (60.9%), Mexico (48.3%), Malawi (37.0%), and South Africa (32.9%).
Conclusions:
- Microsporidia remain a significant opportunistic pathogen in HIV/AIDS patients worldwide.
- Strengthened molecular surveillance and standardized diagnostic protocols are essential.
- Integrating microsporidia screening into routine HIV/AIDS care can improve patient outcomes and control transmission.
Related Concept Videos
Fungal Phylum Microsporidia
Global Climate Change
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Electrogravimetric Analysis: Overview
To test the completeness of the...
Statistical Analysis: Overview
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...

